DOI 10.1016/j.ijid.2026.108578
The clinical diagnostic value of metagenomic next-generation sequencing for patients with suspected nontuberculous mycobacterial osteoarticular infection: A national multicenter clinical cohort.
Аннотация
OBJECTIVES
This study aimed to determine the accuracy of metagenomic next-generation sequencing (mNGS) in diagnosing nontuberculous mycobacteria (NTM) osteoarticular infection (OAI) and compare it with mycobacteria growth indicator tube (MGIT) culture.
METHODS
This study was conducted on 193 patients with suspected NTM OAI treated from January 2019 to July 2022 at the Beijing Chest Hospital, Capital Medical University, Yantai Qishan Hospital, or The Fourth People's Hospital of Nanning who had mNGS assay and MGIT culture results. Clinical comprehensive diagnosis was taken as the "gold standard." We investigated the diagnostic sensitivity, specificity, predictive value, and likelihood ratio of these tests.
RESULTS
Of the 193 patients, 26 (13.47%) were diagnosed with NTM OAI, and 167 (86.53%) had non-NTM OAI. Compared to the MGIT culture results, mNGS showed higher sensitivity (100.0% vs 7.7%), specificity (99.4% vs 80.2%), positive predictive value (96.3% vs 5.7%), negative predictive value (100.0% vs 84.8%), positive likelihood ratio (167.000 vs 0.389), and negative likelihood ratio (0.000 vs 1.150). The area under the curve of the mNGS assay was 0.997 (95% confidence interval, 0.990-1.000).
CONCLUSION
The mNGS assay had greater diagnostic accuracy than the MGIT culture in patients with suspected NTM OAI.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.